Full text
Es e es e al. BMC Res No es (2018) 11:249
h ps://doi.o g/10.1186/s13104-018-3363-0
RESEARCH NOTE
Se e e hypoglycaemia in diabe ic
pa ien s in P e-hospi al and Eme gency
Depa men ca e: a c oss-sec ional su ey
Césa Es e es1,2,3*, Celes ino Ne es1,2,3, João Jaime Sá4 and Da ide Ca alho1,2,3
Abs ac
Objec i e: We aimed o cha ac e ize hypoglycaemia episodes and pa ien s examined by a P e-hospi al Medical
Eme gency Uni (PH) and in he Eme gency Depa men (ED) o ou hospi al.
Resul s: We iden i ied 86 episodes o se e e hypoglycaemia (PH: n 37; ED: n 49; bo h: n 12). Hypoglycaemia
accoun ed o 4.7% o all eme gency calls a ended by he PH (n 793) and 0.11% o all ED episodes (n 54,366). Among
episodes examined by he PH, 64.5% o in ol ed pa ien s had ype 2 diabe es and 54.1% we e no e e ed o he ED.
T anspo a ion o he pa ien o he ED was mo e likely in ype 2 diabe es (p = 0.014). Among episodes e alua ed in
he ED 66.1% o he pa ien s we e mo e han 65 yea s old and 81.4% had ype 2 diabe es. 66% o he pa ien s we e
insulin ea ed. One- hi d o examined pa ien s we e admi ed o he wa d, he majo i y ha ing ype 2 diabe es.
Keywo ds: Hypoglycaemia, Eme gency ca e, Cos s, Diabe es melli us
© The Au ho (s) 2018. This a icle is dis ibu ed unde he e ms o he C ea i e Commons A ibu ion 4.0 In e na ional License
(h p://c ea i ecommons.o g/licenses/by/4.0/), which pe mi s un es ic ed use, dis ibu ion, and ep oduc ion in any medium,
p o ided you gi e app op ia e c edi o he o iginal au ho (s) and he sou ce, p o ide a link o he C ea i e Commons license,
and indica e i changes we e made. The C ea i e Commons Public Domain Dedica ion wai e (h p://c ea i ecommons.o g/
publicdomain/ze o/1.0/) applies o he da a made a ailable in his a icle, unless o he wise s a ed.
In oduc ion
Hypoglycaemia is a majo ba ie o he achie emen o
op imal glycaemic con ol in diabe es (DM) [1, 2]. I is
one o he mos common ad e se e ec s associa ed wi h
an idiabe ic d ugs and is usually ecognized as being
po en ially ha m ul o people wi h diabe es [3, 4]. The
ACCORD [5], ADVANCE [6] and VADT [7] ials dem-
ons a ed an inc ease in mo ali y in he case o in en-
si ely- ea ed pa ien s wi h ype 2 diabe es (T2DM). In
analysing he eason o his, one o he main hypo hesis
is ha mo ali y was associa ed wi h hypoglycaemia isk.
ADA [2] epo s on he subjec conside ha se e e
hypoglycaemia is a condi ion which equi es ano he
pe son o ac i ely adminis e ca bohyd a es, glucagon, o
ake o he co ec i e ac ions. In ype 1 diabe es (T1DM),
he incidence o se e e hypoglycaemia is 115 [8]–320
[9] episodes/pa ien -yea , and se e e hypoglycaemia
may be he cause o dea h o 4–10% [10] o pa ien s. Fo
indi iduals wi h T2DM, he isk o se e e hypoglycaemia
is lowe . I mainly occu s in indi iduals ha ha e been
ea ed wi h sec e agogues o insulin, in olde pa ien s
wi h mul iple como bidi ies, ecen hospi aliza ion and
polymedica ed pa ien s [2]. Hypoglycaemia in DM has
been ecognized as a d i e o inc eased cos s o heal h-
ca e sys ems.
In Po ugal, da a ega ding hypoglycaemia is sca ce
[11] as he e a e no s uc u ed da abases ega ding eme -
gency episodes, and diabe es da abases a e based on
appoin men eco ds which do no include in o ma ion
abou hypoglycaemia [12]. Howe e , in 2015, an es i-
ma ed 13.3% [12] o he popula ion had DM and may be
a isk o ea men induced hypoglycaemia. The au ho s
in end o e alua e he p e alence o hypoglycaemia and
ea men p o ocols implemen ed in he Eme gency
Depa men (ED) o a leading hospi al, and also in he
associa ed P e-hospi al Medical Eme gency Uni (PH),
as well as he c i e ia o admission o he wa d. We will
also look in o he causes o e alua ed hypoglycaemia
episodes.
Open Access
BMC Resea ch No es
*Co espondence: cesa ma queses e [email p o ec ed]
1 Endoc inology, Diabe es and Me abolism Depa men , Cen o
Hospi ala São João, Alameda P o . He nani Mon ei o, 4200-319 Po o,
Po ugal
Full lis o au ho in o ma ion is a ailable a he end o he a icle
Page 2 o 5
Es e es e al. BMC Res No es (2018) 11:249
Main ex
Me hods
We pe o med a e ospec i e c oss-sec ional s udy o
indi iduals wi h DM examined in he P e-hospi al and/
o ED se ing due o hypoglycaemia. Ou da a e e s o
episodes ha ook place be ween he 1s o Janua y and
he 31s o Ma ch, 2010, e alua ed by he PH o in he
ED o ou hospi al, which p o ides ca e in a la ge ci y in
Po ugal. We we en’ able o ex end he s udy pe iod due
o so wa e limi a ions. In Po ugal, P e-hospi al Ca e
is usually made by pa amedic pe sonnel. Some eams
include medical doc o s ha can ea eme gen si u-
a ions in an ou pa ien basis, wi h no need o anspo
he pa ien o he hospi al. All eme gency episodes a e
documen ed in he P e-hospi al Eme gency Uni ile and/
o in he elec onic heal h eco d so wa e used in he
Eme gency Depa men –Ale ©. We sea ched he iles o
he PH and he Ale © so wa e o da a on ED episodes,
using he ICD-9 codes ha a e po en ially associa ed wi h
DM and i s complica ions, o hypoglycaemia: 250 (diabe-
es melli us), 251 (o he diso de s o panc ea ic in e nal
sec e ion), 271 (diso de s o ca bohyd a e anspo and
me abolism), 775.6 (hypoglycaemia) and 962 (poison-
ing by ho mones and syn he ic subs i u es). We excluded
pa ien s wi hou diabe es, as well as codi ica ion e o s.
We eco ded he ollowing a iables: demog aphic da a,
ype o diabe es, an idiabe ic d ugs, diabe es du a ion,
ch onic diabe es complica ions, como bidi ies, p esence
o neu ogenic o neu oglycopenic symp oms, Glasgow
Coma Scale and glycaemia changes du ing he episode.
We iden i ied he episodes ha esul ed in admission o
he Sho S ay Uni (SSU), admission o he wa d and he
como bidi ies ha could be ela ed wi h he decision o
keep he pa ien in obse a ion. The SSU is a wa d whe e
he pa ien can be kep o obse a ion o less han 24h,
a e which i is conside ed o be an admission o he
wa d.
We used Mic oso O ice 2010 Excel and SPSS 20.0
o s a is ical analysis. When applicable, we used he χ2
and Mann–Whi ney es s. The esul s we e exp essed
as mean ± s anda d de ia ion o median [qua iles]. We
conside ed p < 0.05 as signi ican .
Resul s
We e iewed 793 eme gency calls e alua ed by he PH,
o which 37 we e hypoglycaemia episodes (4.7%). We
e iewed 54,366 ED episodes du ing he s udy pe iod o
which 15,517 we e no associa ed wi h a de ini i e diag-
nosis and he e o e we e excluded om he analysis.
Among he emaining 38,849 episodes, we ound 102
episodes, o which 32 we e no associa ed wi h hypogly-
caemia, 8 episodes occu ed in pa ien s wi hou diabe es
and 1 episode ook place in he ED. Fo y- wo episodes
we e diagnosed as “o he speci ied hypoglycaemia” and
19 as “hypoglycaemia, unspeci ied”— o alizing 61 epi-
sodes o hypoglycaemia (0.11% o he o al ED episodes;
0.16% among episodes wi h a de ini i e diagnosis). In
o al, we iden i ied 86 episodes o se e e hypoglycaemia:
37 examined by he PH, o which 12 we e e e ed o he
ED and 49 episodes we e examined in he ED ha had
no been p e iously examined by he PH. The episodes
occu ed wi h 84 pa ien s, as 2 indi iduals had ecu en
hypoglycaemia.
P e‑hospi al Medical Eme gency Uni
Twen y episodes (54.1%) did no esul in e e al o he
ED and 13 (35.1%) occu ed be ween 24.00 and 08.00.
The cha ac e iza ion o he examined pa ien s is p e-
sen ed in Table1. People wi h T1DM we e signi ican ly
younge han pa ien s wi h T2DM [40yea s (35.0–42.5)
s 75yea s (68.5–77.8); p = 0.000; Mann–Whi ney es ],
howe e he e we e no signi ican di e ences in diabe es
du a ion (p = 0.203). All indi iduals wi h T2DM ea ed
wi h o al agen s only we e using sulphonylu eas.
Mean glycemia a p esen a ion was 32 ± 14.9 mg/dL
and only one- hi d o pa ien s e e ed neu ogenic symp-
oms. The e was a p e ious a emp o ea hypoglycae-
mia by a ela i e in six episodes (16.2%). Thi y- i e cases
we e ea ed on si e by a heal h ca e p o essional using
hype onic glucose. The e was no e e ence o use o
glucagon. Episodes in ol ing pa ien s wi h T2DM we e
mo e equen ly associa ed wi h e e al o he ED han
hose in indi iduals wi h T1DM [14 (70.0%) s 3 (25.0%);
p = 0.027; χ2 es ]. Re usal o he pa ien was he eason
why 17.6% o pa ien s we e no e alua ed in he ED.
Eme gency Depa men
Table 1 desc ibes he de ailed in o ma ion o pa ien s
wi h hypoglycemia examined in he ED. The e was a high
p e alence o signi ican como bidi ies, such as ch onic
kidney disease (n 21, 34.4%), hea disease (n 20, 32.8%),
ce eb o ascula disease (n 18, 29.5%), neoplas ic disease
(n 8, 13.5%) and demen ia (n 7, 11.9%). De ails on he use
o o al agen s can be ound in Table2. Nine een pa ien s
we e using sulphonylu eas, o which 8 we e using gliben-
clamide, 5 we e using glimepi ide and 4 we e using gli-
clazide (missing 2).
De ails on hypoglycaemia episodes in he ED can be
ound in Table3. A he ime o a i al o he ED, 30
(49.2%) pa ien s we e hypoglycaemic (mean glycemia
43 ± 16.4mg/dL, 1 below 20mg/dL). Among hese, 16
(26.2%) we e diagnosed in he ED. None o he pa ien s
admi ed in he ED whils hypoglycaemic was p e i-
ously e alua ed by ou PH. In 32 (52.4%) pa ien s, he
mean maximal glycaemia du ing he ED s ay was highe
han 250 mg/dL. The e was a s a is ically signi ican
Page 3 o 5
Es e es e al. BMC Res No es (2018) 11:249
di e ence in Glasgow Coma Scale be ween pa ien s ha
we e admi ed in he ED du ing nigh ime and day ime
[8.5 (3.0–15.0) s 15.0 (13.5–15.0) espec i ely; p = 0.046;
Mann–Whi ney es ].
Diges i e sys em associa ed disease was he mos com-
mon concu en cause o hypoglycemia (n 17, 27.9%),
ollowed by insulin adminis a ion e o (n 8, 13.1%),
acu e kidney inju y (n 7, 11.5%), skipped meal (n 7,
11.5%) and u ina y ac in ec ion (n 6, 9.8%). O he p e-
cipi an s accoun o 13 episodes (21.3%) and 11 (18.0%)
had no iden i ied cause.
Pa ien s’ s ay in he hospi al
Among 19 pa ien s admi ed, 2 s ayed in he SSU o
mo e han 24h and he emaining we e admi ed o he
wa d. In 19 pa ien s, 18 had T2DM, o which 9 we e using
o al agen s only—all wi h sulphonylu ea—6 we e only
using insulin and 3 we e ea ed wi h combined he apy.
O he pa ien s admi ed o he wa d, 11 p esen ed ea-
sons o admission o he han hypoglycaemia: (1) com-
muni y acqui ed pneumoniae (n 4), (2) wo sening kidney
unc ion (n 5), (3) myoca dial in a c ion o decompen-
sa ed hea ailu e (n 3), (4) s oke (n 1), (5) lowe limb
gang ene (n 1) and (6) social easons (n 1).
Hospi al s ay median du a ion was 9days (minimum
3–maximum 130), acco ding o he ype and se e i y o
como bidi ies. 17 (89.4%) pa ien s we e discha ged home
and 2 pa ien s died du ing hospi al s ay.
Follow up a e discha ge om he ED/wa d
Since he ime pe iod o da a analysis up o Sep em-
be 2013, 15 (25.4%) pa ien s died. The median ime lag
be ween se e e hypoglycaemia episode and dea h was
9mon hs (minimum 4–maximum 21). Pa ien s ha died
du ing ollow-up had a mean age o 72.9 ± 11.69yea s
Table 1 Cha ac e iza ion o pa ien s wi h hypoglycaemia examined by he PH (n 37) and in he ED (n 59)
OA o al agen s, DM1 ype 1 diabe es melli us, DM2 ype 2 diabe es melli us, DM3 o he causes o diabe es melli us
P e-hospi al Eme gency Uni Eme gency Depa men
Age (yea s) Mean ± SD: 60.7 ± 18.36
Min–max: 27–84
> 65 yea s: 19 (51.3%)
Mean ± SD: 68.0 ± 15.26
Min–max: 23–93
> 65 yea s: 39 (66.1%)
Gende Men: 10 (27.0%)
Women: 26 (72.3%)
Missing: 1
Men: 28 (47.5%)
Women: 31 (52.5%)
Type o diabe es melli us DM1: 11 (35.5%)
DM2: 20 (64.5%)
Missing: 6
DM1: 5 (8.5%)
DM2: 48 (81.4%)
O he : 6 (10.2%)
Diabe es du a ion (yea s) 19.1 ± 8.37
Min–max: 10–30 16.2 ± 10.25
Min–max: 0–37
His o y o diabe es complica ions – Yes: 35 (59.3%)
No: 24 (40.7%)
His o y o se e e hypoglycaemia Yes: 8
Missing: 29 Yes: 12 (20.3%)
No: 47 (79.7%)
An idiabe ic agen s Only OA: 5 (26.3%)
Only insulin: 9 (47.4%)
OA plus insulin: 5 (26.3%)
Missing: 18
Only OA: 20 (33.9%)
Only insulin: 30 (50.8%)
OA plus Insulin: 9 (15.2%)
Table 2 Use o o al agen s in people wi h diabe es admi -
ed in he ED o hypoglycemia
DPPI DPP-IV inhibi o , SU sulphonylu ea, TZD hiazolidinedione, AGI alpha-
glucosidase inhibi o
Subg oups D ug class combina ion n
O al agen s only, wi hou SU +Me o min and DPPI 1
+TZD 1
Missing 1
Sub o al 3
O al agen s only, including SU Mono he apy 5
+Me o min 7
+DPPI 1
+DPPI and me o min 3
+Me o min and AGI 1
Sub o al 17
O al agen s plus insulin +Me o min 3
+Me o min and DPPI 2
+Me o min, DPPI and SU 1
+Me o mina and AGI 1
+Me o min, TZD and SU 1
Missing 1
Sub o al 9
To al 29
Page 4 o 5
Es e es e al. BMC Res No es (2018) 11:249
and se e e como bidi ies. Among hese, ascula disease
(n 9) and ch onic kidney disease (n 7) we e pa icula ly
p e alen .
Discussion
We ound a signi ican p e alence o se e e hypoglycae-
mia among pa ien s e alua ed by a PH. A s udy published
in 2006 [13] ound ha hypoglycaemia is he mos com-
mon eason o eme gency calls ela ed o diabe es o
an idiabe ic he apy, accoun ing o 51% o e alua ions.
We con i med ha he equency o e e al o he ED
among pa ien s wi h T2DM is signi ican ly highe han
among indi iduals wi h T1DM, as p e iously desc ibed
[11].
In p e ious li e a u e, he p e alence o se e e hypogly-
caemia in he ED is 0.37–0.4% [14, 15]. We ound a lowe
igu e, which migh be ela ed o he ac ha he p e i-
ous s udies ook place se e al yea s ago, and ha he p e-
sc ip ion pa e n o an idiabe ic d ugs di e ed om ha
o 2010, as well as ecommended glucose a ge s. In Po -
ugal, mos new insulins a e ully and mos o al agen s
a e pa ially eimbu sed.
In one s udy [13], 93% o pa ien s was using insulin
and only 1 pa ien did no ha e documen ed hypogly-
caemia in he p e-hospi al con ex . In ou se ies, 54.4%
o pa ien s we e using insulin (56.3% among indi idu-
als wi h T2DM) and 16 (26.2%) we e diagnosed in he
ED. I may be ha , in ou a ea, pa ien s and hei ela-
i es migh no ha e su icien he apeu ic educa ion o
he p e en ion, iden i ica ion and adequa e managemen
o hypoglycaemia episodes. I is necessa y o de e mine
wha he di icul ies a e o p e-hospi al diagnosis/e alu-
a ion o hypoglycaemia.
Rega ding hypoglycaemia ea men modali y, IV glu-
cose was he p e e ed ea men while o he au ho s
[13] no ed a high p e alence o glucagon-use. The same
au ho s ound ha mos pa ien s a i ed a he ED s ill
su e ing om hypoglycaemia. In ou s udy, nea ly hal
o he pa ien s we e admi ed in ha condi ion. This may
be ela ed o: (1) inadequa e p e-hospi al diagnosis; (2)
e e al o pa ien s o he ED by ela i es due o symp-
oms associa ed wi h undiagnosed hypoglycaemia; (3)
he pa ien was unable o inges ca bohyd a e and did
no ha e access o IV glucose o glucagon. E e y pa ien
e alua ed by ou PH was adequa ely ea ed be o e a i -
ing a he ED.
Rega ding he use o hypoglycaemic d ugs, insulin
seems o be he mos equen agen associa ed wi h
se e e hypoglycaemia. Nine een pa ien s we e using
sulphonylu eas and, amongs hem, 17 we e no using
insulin.
The equency o admission o he wa d o p olonged
obse a ion was 31.1%, whils B acken idge [13] ound an
admission a e o 11%. The e a e p obably egional di e -
ences in c i e ia o admission o he wa d. The e is o en
an associa ion wi h in e cu en illness which may also
be a ac o esponsible o he ele a ed epo ed cos s o
hypoglycaemia.
Donnelly [8] also ound a high mo ali y a e se e e
hypoglycaemia, which is sugges i e o i s alue as a p og-
nos ic ac o . Despi e no being able o de e mine he
cause o dea h, he high p e alence o se e e como bidi-
ies in pa ien s su e ing se e e hypoglycaemia is o el-
e ance [16].
Conclusions
We ound ha many pa ien s a en’ adequa ely e alu-
a ed and ea ed be o e being e e ed o he Eme gency
Depa men . Hypoglycemia is a equen cause o eme -
gency calls and only a mino i y hose is e alua ed in he
Eme gency Depa men . Mos indi iduals e alua ed in
his con ex use insulin.
Table 3 Cha ac e iza ion o se e e hypoglycaemia epi-
sodes eco ded in he Eme gency Depa men (n 61)
Glycaemia (mg/dL) On si e: 38 ± 13.7 (3 below 20 mg/dL)
Minimum–maximum: 20–68
ED a i al: 103 ± 80.5
Minimum–maximum: 20–349
Pa ien s e alua ed by ou PH:
202 ± 82.6
Glasgow coma scale All episodes: 14.0 (5.5–15.0)
Noc u nal: 8.5 (3.0–15.0)
Diu nal: 15.0 (13.5–15.0)
Adminis a ion o ea men on
si e Rela i e: 15 (24.6%)
Heal h p o essional: 26 (42.6%)
Type o ea men on si e (a ail-
able in o ma ion in 24 cases) Hype onic glucose: 13
Pe os: 10
Glucagon: 1
Type o ea men in he ED 56 (91.8%) pa ien s ecei ed any kind
o ea men
Pe os: 2
Hype onic glucose: 23 (mean
2.2 ± 0.79 ials)
Glucose 5–10% solu ion: 31
Maximal glycaemia du ing ED
s ay (mmol/L) 256 ± 90.9
Minimum–maximum: 85–Hi
Wo kup eques ed? Yes: 52 (85.2%)
No: 9 (14.8%)
Admission in he sho s ay uni Yes: 18 (29.5%)
No: 43 (70.5%)
ED s ay du a ion (h) 17.2 ± 1.27
Discha ge des ina ion Home: 40 (65.6%)
O he acili y: 2 (3.3%)
Wa d: 19 (31.1%)
Page 5 o 5
Es e es e al. BMC Res No es (2018) 11:249
•
as , con enien online submission
•
ho ough pee e iew by expe ienced esea che s in you ield
•
apid publica ion on accep ance
•
suppo o esea ch da a, including la ge and complex da a ypes
•
gold Open Access which os e s wide collabo a ion and inc eased ci a ions
maximum isibili y o you esea ch: o e 100M websi e iews pe yea
•
A BMC, esea ch is always in p og ess.
Lea n mo e biomedcen al.com/submissions
Ready o submi you esea ch
? Choose BMC and bene i om:
Limi a ions
We ound a signi ican numbe o ED episodes wi h
unspeci ied diagnosis, which may a bo a numbe o
inco ec ly codi ied hypoglycaemia episodes. Episodes
associa ed wi h speci ied consequences o hypoglycaemia
may ha e been codi ied wi hou e e ence o hypoglycae-
mia. We we e no able o de e mine he p e alence o use
o speci ic insulin ea men egimens. Causes o hypo-
glycaemia we e de e mined by he ea ing physician.
These esul s may no be gene alizable o pa ien s om
o he egions.
Abb e ia ions
T1DM: ype 1 diabe es melli us; T2DM: ype 1 diabe es melli us; PH: P e-
hospi al Eme gency Uni ; ED: Eme gency Depa men ; SSU: Sho S ay Uni .
Au ho s’ con ibu ions
CE: s udy p o ocol, da a collec ion, s a is ical wo k, manusc ip ; CN, JJS and
DC: s udy p o ocol, e iew o manusc ip . All au ho s ead and app o ed he
inal manusc ip .
Au ho de ails
1 Endoc inology, Diabe es and Me abolism Depa men , Cen o Hospi a-
la São João, Alameda P o . He nani Mon ei o, 4200-319 Po o, Po ugal.
2 Facul y o Medicine, Uni e si y o Po o, Alameda P o . He nani Mon ei o,
4200-319 Po o, Po ugal. 3 Ins i u e o Resea ch and Inno a ion in Heal h,
Po o, Po ugal. 4 Eme gency Depa men , Cen o Hospi ala São João, Po o,
Po ugal.
Acknowledgemen s
Rui Baldaia, Eme gency Depa men , Cen o Hospi ala São João, o his con i-
bu ion o acquisi ion o da a.
These esul s we e pa ially published in he ollowing abs ac s:
Es e es C, Ne es MC, Baldaia R, Sá J, Ca alho D: Cha ac e iza ion o he
episodes o se e e hypoglycemia e alua ed by a P e-hospi al Ca e uni o a
e e ence hospi al. Endoc ine Abs ac s, 2014;35:390.
Es e es C, Ne es MC, Baldaia R, Sá J, Ca alho D: Cha ac e iza ion o se e e
hypoglycemia episodes e alua ed in he Eme gency Depa men o a Cen al
Hospi al. Endoc ine Abs ac s, 2014;35:389.
Compe ing in e es s
The au ho s decla e ha hey ha e no compe ing in e es s.
A ailabili y o da a and ma e ials
Con ac he co esponding au ho o ob ain access o he da ase .
Consen o publica ion
No applicable.
E hics app o al and consen o pa icipa e
The s udy p o ocol was app o ed by he E hics Comi ee o Cen o Hospi ala
São João. Consen o pa icipa e no applicable. In o med consen o access
he medical eco ds was ob ained om he hospi al adminis a ion.
Funding
The au ho s did no ecei e any unding o his pape .
Publishe ’s No e
Sp inge Na u e emains neu al wi h ega d o ju isdic ional claims in pub-
lished maps and ins i u ional a ilia ions.
Recei ed: 6 Decembe 2017 Accep ed: 18 Ap il 2018
Re e ences
1. C ye PE. Glucose homeos asis and hypoglycaemia. In: K onenbe g HM,
Melmed S, Polonsky KS, La sen PR, edi o s. Williams ex book o endoc i-
nology. New Yo k: Else ie ; 2008. p. 1503–36.
2. Seaquis ER, Ande son J, Childs B, e al. Hypoglycaemia and diabe es:
a epo o a wo kg oup o he ame ican diabe es associa ion and he
endoc ine socie y. Diabe es Ca e. 2013;36:1384–95.
3. Ley on O. Pe sis en hypoglycaemia ollowing diabe es melli us ea ed
wi h insulin. P oc R Soc Med. 1929;22:1225–6.
4. Macphe son WE. Hypoglycaemia in diabe es. Cal Wes Med.
1935;42(6):475.
5. Ge s ein HC, Mille ME, Bying on RP, Ac ion o Con ol Ca dio ascula Risk
in Diabe es S udy G oup, e al. E ec s o in ensi e glucose lowe ing in
ype 2 diabe es. N Engl J Med. 2008;358:2545–59.
6. Pa el A, MacMahon S, Chalme s J, ADVANCE Collabo a i e G oup, e al.
In ensi e blood glucose con ol and ascula ou comes in pa ien s wi h
ype 2 diabe es. N Engl J Med. 2008;358:2560–72.
7. Duckwo h W, Ab ai a C, Mo i z T, VADT In es iga o s, e al. Glucose con-
ol and ascula complica ions in e e ans wi h ype 2 diabe es. N Engl J
Med. 2009;360:129–39.
8. Donnelly LA, Mo is AD, F ie BM, DARTS/MEMO Collabo a ion, e al.
F equency and p edic o s o hypoglycaemia in ype 1 and insulin- ea ed
Type 2 diabe es: a popula ion-based s udy. Diabe Med. 2005;22:749–55.
9. Helle SR, Choudha y P, Da ies C, UK S udy G oup, e al. Risk o hypogly-
caemia in ypes 1 and 2 diabe es: e ec s o ea men modali ies and
hei du a ion. Diabe ologia. 2007;50:1140–7.
10. Pa e son CC, Dahlquis G, Ha ju salo V, e al. Ea ly mo ali y in EURODIAB
popula ion-based coho s o ype 1 diabe es diagnosed in childhood
since 1989. Diabe ologia. 2007;50:2439–42.
11. Figuei a Coelho J, Bu gi Viei a C, Lou enço S, Ma ins Ba is a A. Ca ac e i-
zação das Hipoglicémias Se e as em Doen es Diabé icos Assis idos po
uma Via u a Médica de Eme gência e Reanimação. Re is a Po uguesa de
Diabe es. 2010;5(3):100–5.
12. Obse a ó io Nacional da Diabe es: Diabe es: Fac os e Núme os—O Ano
de 2015. h p://spd.p /images/OND/DFN2015.pd .
13. B acken idge A, Wallbank H, Law enson RA, Russell-Jones D. Eme -
gency managemen o diabe es and hypoglycaemia. Eme g Med J.
2006;23:183–5.
14. Ginde A, Espinola J, Cama go C. T ends and dispa i ies in US Eme -
gency Depa men isi s o hypoglycaemia: 1993–2005. Diabe es Ca e.
2008;31:511–3.
15. Ha SP, F ie BM. Causes, managemen and mo bidi y o acu e hypogly-
caemia in adul s equi ing hospi al admission. Q J Med. 1998;91:505–10.
16. Zoungas S, Pa el A, Chalme s J, e al. Se e e hypoglycaemia and isks o
ascula e en s and dea h. N Engl J Med. 2010;363:1410–8.